S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Modern Day Options Trading For Beginners! (Ad)pixel
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Bank Accounts: Frozen! (Ad)
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Modern Day Options Trading For Beginners! (Ad)pixel
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Bank Accounts: Frozen! (Ad)
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Modern Day Options Trading For Beginners! (Ad)pixel
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Bank Accounts: Frozen! (Ad)
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Modern Day Options Trading For Beginners! (Ad)pixel
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Bank Accounts: Frozen! (Ad)
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
NASDAQ:CFMS

Conformis - CFMS Price Target & Analyst Ratings

$1.14
-0.06 (-5.00%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.10
$1.25
50-Day Range
$1.14
$3.05
52-Week Range
$1.10
$18.72
Volume
66,199 shs
Average Volume
52,418 shs
Market Capitalization
$8.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.50

Conformis Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 2 Analyst Ratings

Consensus Analyst Price Target

$4.50
294.74% Upside
High Prediction$8.00
Average Prediction$4.50
Low Prediction$1.00
TypeCurrent
3/28/22 to 3/28/23
1 Month Ago
2/26/22 to 2/26/23
3 Months Ago
12/28/21 to 12/28/22
1 Year Ago
3/28/21 to 3/28/22
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
1 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$4.50$4.50$4.50$2.00
Predicted Upside294.74% Upside424.78% Upside424.78% Upside69.49% Upside
Get Conformis Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CFMS and its competitors with MarketBeat's FREE daily newsletter.

CFMS Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CFMS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Conformis Stock vs. The Competition

TypeConformisMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.64
2.47
Consensus RatingBuyBuyHold
Predicted Upside294.74% Upside2,002.72% Upside22.47% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/11/2022Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$1.25 ➝ $8.00+463.38%
8/11/2022Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Kyle Rose
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$2.00 ➝ $1.00+238.97%
11/8/2020Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform$2.00+203.95%
5/12/2020BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingHold
(Data available from 3/28/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












CFMS Price Target - Frequently Asked Questions

What is Conformis's consensus rating and price target?

According to the issued ratings of 2 analysts in the last year, the consensus rating for Conformis stock is Buy based on the current 2 buy ratings for CFMS. The average twelve-month price prediction for Conformis is $4.50 with a high price target of $8.00 and a low price target of $1.00. Learn more on CFMS's analyst rating history.

Do Wall Street analysts like Conformis more than its competitors?

Analysts like Conformis more than other Medical companies. The consensus rating score for Conformis is 3.00 while the average consensus rating score for medical companies is 2.64. Learn more on how CFMS compares to other companies.

Does Conformis's stock price have much upside?

According to analysts, Conformis's stock has a predicted upside of 424.78% based on their 12-month price targets.


Stock Ratings Reports and Tools

This page (NASDAQ:CFMS) was last updated on 3/28/2023 by MarketBeat.com Staff